KLOW 80mg
£69.99
KLOW – 80mg lyophilised blend, research grade. Multi-peptide formulation (GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg) for in-vitro research use only.
6 in stock
For In-Vitro Research Use Only. Not for human consumption, veterinary use, or clinical application. No dosing guidance is provided or implied.
KLOW is a co-lyophilised multi-peptide research blend containing four compounds in a single vial:
- GHK-Cu 50mg – naturally occurring human tripeptide-copper complex
- BPC-157 10mg – synthetic pentadecapeptide derived from human gastric juice protein
- TB-500 10mg – synthetic analogue of Thymosin Beta-4
- KPV 10mg – C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone
This formulation is designed for research protocols investigating multiple signalling pathways simultaneously. The constituent peptides have been individually studied across models of tissue remodelling, cytoprotection, cell migration, angiogenesis, and inflammatory modulation.
KLOW is supplied as a single co-lyophilised vial. Researchers requiring individual compounds for independent assays should purchase the separate products.
For In-Vitro Research Use Only. Not for human consumption, veterinary use, or clinical application. No dosing guidance is provided or implied.
| Purity | >=98% HPLC |
| Form | Lyophilised powder (co-lyophilised blend) |
| Vial Size | 80mg total (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg) |
| Storage | -20C (lyophilised); 2-8C (reconstituted) |
Peer-reviewed published research underpins every compound in our catalogue. All products are supplied strictly for research use only.
Related products
